Study S000050

Effects of Exenatide (Byetta®) on Biochemical and Histological Parameters of Liver Function in Patients With Nonalcoholic Steatohepatitis (NASH)

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT01208649
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE4
Masking: TRIPLE
Status: COMPLETED
Enrollment: 13
Start: 2008-07
Primary completion: 2010-09
Lead sponsor: Ruhr University of Bochum
Conditions: Nonalcoholic Fatty Liver Disease
Interventions: DRUG:Exenatide
Results posted: FALSE

Registered primary outcomes

histological activity of NASH (steatosis, necroinflammation, ballooning) [24 weeks]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.